Norris Perne & French LLP Novartis Ag Transaction History

Norris Perne & French LLP

$1.31 Billion
Q1 2024

A detailed history of Norris Perne & French LLP transactions in Novartis Ag stock. As of the latest transaction made, Norris Perne & French LLP holds 2,797 shares of NVS stock, worth $302,243. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,797

Previous 3,363 16.83%

Holding current value

$302,243

Previous $339,000 20.35%

% of portfolio

0.02%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$95.27 - $108.47 $53,922 - $61,394	-566 Reduced 16.83%	2,797 $270,000
Q4 2023 Jan 22, 2024	SELL	$92.27 - $101.54 $922 - $1,015	-10 Reduced 0.3%	3,363 $339,000
Q3 2023 Oct 18, 2023	SELL	$94.73 - $105.13 $47,649 - $52,880	-503 Reduced 12.98%	3,373 $343,000
Q2 2023 Jul 19, 2023	SELL	$92.52 - $104.91 $6,291 - $7,133	-68 Reduced 1.72%	3,876 $391,000
Q1 2023 Apr 20, 2023	BUY	$80.03 - $92.81 $720 - $835	9 Added 0.23%	3,944 $362,000

Q2 2022 Aug 11, 2022	SELL	$80.52 - $93.75 $38,810 - $45,187	-482 Reduced 10.91%	3,935 $333,000
Q1 2022 Apr 26, 2022	SELL	$80.11 - $90.62 $123,129 - $139,282	-1,537 Reduced 25.81%	4,417 $388,000
Q4 2021 Jan 26, 2022	SELL	$79.7 - $88.13 $533,511 - $589,942	-6,694 Reduced 52.93%	5,954 $521,000
Q3 2021 Oct 26, 2021	SELL	$81.78 - $95.14 $10,631 - $12,368	-130 Reduced 1.02%	12,648 $1.03 Million
Q2 2021 Jul 20, 2021	SELL	$85.24 - $94.15 $15.9 Million - $17.6 Million	-186,859 Reduced 93.6%	12,778 $1.17 Million
Q1 2021 Apr 30, 2021	SELL	$83.5 - $98.47 $276,218 - $325,738	-3,308 Reduced 1.63%	199,637 $17.1 Million
Q4 2020 Jan 27, 2021	BUY	$78.07 - $94.43 $2.14 Million - $2.59 Million	27,411 Added 15.62%	202,945 $19.2 Million
Q3 2020 Oct 26, 2020	BUY	$82.14 - $91.0 $312,460 - $346,164	3,804 Added 2.22%	175,534 $15.3 Million
Q2 2020 Jul 23, 2020	BUY	$80.93 - $91.1 $452,236 - $509,066	5,588 Added 3.36%	171,730 $15 Million
Q1 2020 Apr 16, 2020	BUY	$70.67 - $99.01 $2.31 Million - $3.24 Million	32,750 Added 24.55%	166,142 $13.7 Million
Q4 2019 Jan 22, 2020	SELL	$84.35 - $95.37 $51,284 - $57,984	-608 Reduced 0.45%	133,392 $12.6 Million
Q3 2019 Oct 24, 2019	SELL	$85.54 - $94.26 $26,346 - $29,032	-308 Reduced 0.23%	134,000 $11.6 Million
Q2 2019 Jul 19, 2019	SELL	$75.4 - $92.8 $64,014 - $78,787	-849 Reduced 0.63%	134,308 $12.3 Million
Q1 2019 Apr 29, 2019	BUY	$75.32 - $86.15 $236,128 - $270,080	3,135 Added 2.37%	135,157 $13 Million
Q4 2018 Jan 28, 2019	BUY	$73.66 - $82.02 $173,690 - $193,403	2,358 Added 1.82%	132,022 $11.3 Million
Q3 2018 Oct 29, 2018	BUY	$66.94 - $77.43 $343,067 - $396,828	5,125 Added 4.12%	129,664 $11.2 Million
Q2 2018 Jul 24, 2018	BUY	$64.91 - $73.36 $175,906 - $198,805	2,710 Added 2.22%	124,539 $9.41 Million
Q1 2018 Apr 17, 2018	BUY	$70.39 - $84.15 $25,903 - $30,967	368 Added 0.3%	121,829 $9.85 Million
Q4 2017 Jan 23, 2018	BUY	$72.33 - $77.64 $21,843 - $23,447	302 Added 0.25%	121,461 $10.2 Million
Q3 2017 Nov 01, 2017	BUY	$74.14 - $77.27 $8.98 Million - $9.36 Million	121,159	121,159 $10.4 Million

Others Institutions Holding NVS

# of Institutions

1,350

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $232B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

News

Stay updated on Norris Perne & French LLP with notifications on news.

Account

Norris Perne & French LLP Novartis Ag Transaction History